Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Acquisitions | $26.7M | 1 | 92.8% |
| Current or prospective ownership or investment interest | $2.1M | 10 | 7.2% |
| Consulting Fee | $9,235 | 2 | 0.0% |
| Food and Beverage | $6,221 | 29 | 0.0% |
| Travel and Lodging | $5,476 | 6 | 0.0% |
| Entertainment | $416.68 | 6 | 0.0% |
| Education | $84.99 | 1 | 0.0% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Henry Schein, Inc. | $26.7M | 3 | $0 (2024) |
| TriMed, Inc. | $2.1M | 42 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $160.45 | 6 | $0 (2022) |
| Exactech, Inc. | $80.22 | 1 | $0 (2017) |
| Arthrosurface Incorporated | $76.99 | 1 | $0 (2019) |
| Bioventus LLC | $53.26 | 2 | $0 (2022) |
| Smith & Nephew, Inc. | $25.65 | 1 | $0 (2017) |
| FIDIA PHARMA USA INC. | $21.72 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.7M | 5 | Henry Schein, Inc. ($26.7M) |
| 2022 | $747,704 | 6 | TriMed, Inc. ($747,661) |
| 2021 | $532,183 | 3 | TriMed, Inc. ($532,183) |
| 2020 | $54,877 | 4 | TriMed, Inc. ($54,877) |
| 2019 | $736,969 | 18 | TriMed, Inc. ($736,770) |
| 2018 | $10,796 | 11 | TriMed, Inc. ($10,760) |
| 2017 | $3,542 | 10 | TriMed, Inc. ($3,403) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | Henry Schein, Inc. | — | Food and Beverage | In-kind items and services | $122.87 | General |
| 09/15/2024 | Henry Schein, Inc. | — | Food and Beverage | In-kind items and services | $33.01 | General |
| 04/01/2024 | Henry Schein, Inc. | — | Acquisitions | Cash or cash equivalent | $26,745,896.44 | General |
| 2024 | TriMed, Inc. | — | — | — | $0.00 | Ownership |
| 2024 | TriMed, Inc. | — | — | — | $0.00 | Ownership |
| 09/07/2022 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: ORTHOPEDIC | ||||||
| 06/24/2022 | TriMed, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $400,000.00 | General |
| 06/02/2022 | TriMed, Inc. | — | Food and Beverage | Cash or cash equivalent | $67.53 | General |
| 06/02/2022 | TriMed, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.92 | General |
| 04/12/2022 | TriMed, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $347,564.72 | General |
| 03/01/2022 | Bioventus LLC | Exogen Ultrasound Bone Healing System (Device) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: Not Applicable | ||||||
| 09/27/2021 | TriMed, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $32,064.86 | General |
| 07/08/2021 | TriMed, Inc. | — | Food and Beverage | Cash or cash equivalent | $118.52 | General |
| 04/27/2021 | TriMed, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $500,000.00 | General |
| 09/29/2020 | TriMed, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $52,700.00 | General |
| 01/24/2020 | TriMed, Inc. | — | Travel and Lodging | Cash or cash equivalent | $1,249.92 | General |
| 01/24/2020 | TriMed, Inc. | — | Food and Beverage | Cash or cash equivalent | $868.35 | General |
| 01/07/2020 | TriMed, Inc. | — | Food and Beverage | Cash or cash equivalent | $58.63 | General |
| 10/16/2019 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: ORTHOPEDIC | ||||||
| 10/04/2019 | TriMed, Inc. | — | Food and Beverage | Cash or cash equivalent | $119.44 | General |
| 10/04/2019 | TriMed, Inc. | — | Food and Beverage | Cash or cash equivalent | $12.56 | General |
| 09/30/2019 | TriMed, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $195,428.89 | General |
| 09/23/2019 | TriMed, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $52,700.00 | General |
| 09/23/2019 | TriMed, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $7,816.92 | General |
| 07/26/2019 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Education | In-kind items and services | $84.99 | General |
| Category: ORTHOPEDIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 148 | 220 | $29,232 | $9,757 |
| 2022 | 5 | 107 | 144 | $18,115 | $6,641 |
| 2021 | 7 | 171 | 223 | $27,236 | $10,741 |
| 2020 | 5 | 120 | 158 | $18,249 | $6,418 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 68 | $7,838 | $4,438 | 56.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $4,955 | $2,019 | 40.8% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 21 | 34 | $6,319 | $1,428 | 22.6% |
| 20605 | Aspiration and/or injection of fluid from medium joint | Office | 2023 | 11 | 18 | $3,395 | $647.47 | 19.1% |
| 76000 | Imaging guidance for procedure, 60 minutes or less | Office | 2023 | 12 | 16 | $4,555 | $587.69 | 12.9% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 11 | 16 | $1,464 | $443.68 | 30.3% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2023 | 28 | 45 | $706.87 | $192.17 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 63 | $7,226 | $4,166 | 57.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $3,879 | $1,065 | 27.5% |
| 20550 | Injection into tendon or ligament | Office | 2022 | 14 | 19 | $3,534 | $750.64 | 21.2% |
| 73110 | X-ray of wrist, minimum of 3 views | Office | 2022 | 14 | 23 | $3,147 | $614.23 | 19.5% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2022 | 14 | 21 | $329.89 | $45.52 | 13.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 76 | $8,717 | $5,133 | 58.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 27 | 27 | $5,817 | $2,351 | 40.4% |
| 20550 | Injections of tendon sheath, ligament, or muscle membrane | Office | 2021 | 24 | 29 | $5,390 | $1,214 | 22.5% |
| 73110 | X-ray of wrist, minimum of 3 views | Office | 2021 | 13 | 26 | $3,558 | $919.00 | 25.8% |
| 73140 | X-ray of fingers, minimum of 2 views | Office | 2021 | 16 | 18 | $1,651 | $574.20 | 34.8% |
| 73120 | X-ray of hand, 2 views | Office | 2021 | 14 | 18 | $1,647 | $479.06 | 29.1% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2021 | 25 | 29 | $455.59 | $71.01 | 15.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 46 | 66 | $7,572 | $3,648 | 48.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 19 | 19 | $4,094 | $1,266 | 30.9% |
| 20550 | Injections of tendon sheath, ligament, or muscle membrane | Office | 2020 | 19 | 23 | $4,282 | $919.30 | 21.5% |
| 73120 | X-ray of hand, 2 views | Office | 2020 | 12 | 20 | $1,830 | $514.77 | 28.1% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2020 | 24 | 30 | $471.30 | $69.87 | 14.8% |
About Dr. Robert Medoff, MD
Dr. Robert Medoff, MD is a Orthopaedic Surgery healthcare provider based in Kailua, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508830258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Medoff, MD has received a total of $28.8M in payments from pharmaceutical and medical device companies, with $26.7M received in 2024. These payments were reported across 57 transactions from 8 companies. The most common payment nature is "Acquisitions" ($26.7M).
As a Medicare-enrolled provider, Medoff has provided services to 546 Medicare beneficiaries, totaling 745 services with total Medicare billing of $33,557. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Orthopaedic Surgery
- Location Kailua, HI
- Active Since 02/16/2006
- Last Updated 01/03/2024
- Taxonomy Code 207X00000X
- Entity Type Individual
- NPI Number 1508830258
Products in Payments
- XIAFLEX (Biological) $160.45
- EQUINOXE (Device) $80.22
- HemiCAP Wrist (Device) $76.99
- Exogen Ultrasound Bone Healing System (Device) $29.77
- TRIGEN InterTAN (Device) $25.65
- Exogen (Device) $23.49
- HYALGAN (Device) $21.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.